Humacyte Inc. (HUMAW)
undefined
undefined%
At close: undefined

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - 1.56M 1.26M 1.49M 6.19M
Cost of Revenue 76.55M 8.26M 49.00K 8.43M 75.60M
Gross Profit -76.55M -6.69M 1.21M -6.94M -69.42M
Operating Income -100.05M -84.58M -81.21M -64.60M -85.69M
Interest Income - 2.63M 16.00K 278.00K 269.00K
Pretax Income -110.78M -11.96M -26.48M -66.52M -85.42M
Net Income -110.78M 64.22M 37.54M -68.73M -85.42M
Selling & General & Admin 20.39M 22.88M 21.13M 12.01M 16.27M
Research & Development 76.55M 63.26M 61.34M 54.08M 75.60M
Other Expenses -73.44M -1.56M -1.26M -1.49M -
Operating Expenses 23.50M 84.58M 81.21M 64.60M 16.27M
Interest Expense 1.13M 6.20M 4.35M 2.20M 2.30M
Selling & Marketing Expenses -3.00M - - - -
Cost & Expenses 100.05M 84.58M 81.21M 64.60M 91.88M
Income Tax - -76.18M -64.01M 2.20M -
Shares Outstanding (Basic) 103.42M 103.05M 39.97M 12.45M 20.12M
Shares Outstanding (Diluted) 103.42M 103.05M 39.97M 12.45M 20.12M
EPS (Basic) -1.07 0.62 0.94 -5.52 -4.25
EPS (Diluted) -1.07 0.62 0.94 -5.52 -4.25
EBITDA -96.46M 2.49M -72.97M -56.25M -78.94M
Depreciation & Amortization 7.72M 8.26M 8.28M 8.43M 6.75M